Follistatin 344: What It Is and What Research Shows
What Is Follistatin 344?
Your body has a built-in muscle-growth limiter called myostatin. Think of it as a governor on a car engine — it keeps muscle from growing too large. Follistatin 344 (often written FS-344) is a protein that binds to myostatin and essentially switches that limiter off.
The "344" refers to the number of amino acids (the building blocks of proteins) in this particular version of the follistatin molecule. Your body makes follistatin naturally. The versions circulating in research and gray-market circles are synthetic copies produced in a lab.
Why Are Researchers Interested?
The core idea is straightforward: if you block the brake on muscle growth, muscles grow more. That makes FS-344 interesting for several research areas:
- Muscle-wasting diseases — conditions like muscular dystrophy where patients lose muscle mass rapidly.
- Livestock agriculture — producing leaner meat more efficiently.
- Athletic performance — a controversial application with major regulatory implications.
What Do Animal Studies Show?
The most compelling data come from animals. In one study, scientists created transgenic pigs that expressed the human FS-344 gene specifically in muscle tissue. The result? Significantly more skeletal muscle mass and less body fat compared to normal pigs, with no signs of heart muscle enlargement or reproductive problems in the animals tested.[4] The muscle fibers themselves grew larger — a process called hypertrophy — and key growth-signaling pathways were more active.
Similar findings have been reported in genetically engineered mice. These animal results are genuinely striking, which is partly why interest in FS-344 has spread well beyond academic labs.
What About Human Evidence?
Here is where enthusiasm needs to pump the brakes. A 2026 review in Sports Medicine that evaluated peptides used for musculoskeletal injuries and athletic performance concluded that while many unapproved peptides — including FS-344 — show promising results in animal models, rigorous human safety data are scarce, and the potential for serious harm is real.[2] No large, controlled clinical trials in healthy humans have been published.
The same review highlighted that social media can amplify a placebo effect, meaning people feel a compound is working even when the evidence does not support it.[2] That is an important caution when evaluating anecdotal reports online.
Known Risks: A Serious Eye Warning
One of the most striking safety signals came from a Turkish ophthalmology clinic. Doctors reported 11 male bodybuilders who developed central serous chorioretinopathy (CSCR) — a condition where fluid leaks under the retina and blurs vision — after injecting high doses of FS-344.[3]
CSCR is the medical term for fluid buildup behind the retina. In plain language: their vision deteriorated after using this compound. For the eight patients who had used it only once, the fluid cleared up on its own within about two months. For the three who had used it multiple times, the condition came back.[3] The authors concluded that FS-344 use should be considered a risk factor for this eye condition.
The Black-Market Problem
FS-344 has no approved pharmaceutical form anywhere in the world. That means every vial sold online is unregulated. Anti-doping researchers who analyzed 17 black-market FS-344 products found that only 9 of them actually contained follistatin at all.[5] The others contained different compounds entirely — including growth-promoting peptides like MGF and GHRP-2 — without disclosing that on the label.[5]
A follow-up erratum to that study confirmed the detection methodology.[1] The takeaway: you often cannot know what you are actually getting. Follistatin is also explicitly banned by the World Anti-Doping Agency (WADA) under its list of prohibited substances.[5]
Where Does This Leave Us?
FS-344 is a fascinating molecule with real biological effects — at least in animals. The science of blocking myostatin to grow muscle is not fantasy. But the gap between exciting animal data and proven, safe human use is wide, and the risks documented so far (including vision problems and unknown product contents) are serious.
For researchers and curious readers who want to understand the dosing parameters studied in preclinical and early-phase contexts, our Follistatin 344 dosage chart summarizes what the literature reports. You can also use the calculator to explore how variables like body weight factor into research protocols. Both tools are for educational reference only — not medical guidance.
This article is for research and educational purposes. It is not medical advice. Consult a qualified healthcare professional before considering any peptide or experimental compound.
Sources
- Detection of black market follistatin 344. — Drug testing and analysis, 2020. PMID 33460286.
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. — Sports medicine (Auckland, N.Z.), 2026. PMID 41966639.
- Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series. — International ophthalmology, 2020. PMID 32671599.
- The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs. — Transgenic research, 2017. PMID 27787698.
- Detection of black market follistatin 344. — Drug testing and analysis, 2019. PMID 31758732.